We investigated by flow cytometry whether TNC influenced CD8 TIL function in vivo through CXCL12, by blocking CXCR4 with AMD (for 2 weeks) in tumor‐bearing mice in the 4‐week model (Figs EV2 and EV4A–H). Here, CD8A is linked to neoplasm.